A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
Clinical trial NCT07143604 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07143604
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2026-09-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.